H. Rojas-Cabrera et al. / Tetrahedron: Asymmetry 19 (2008) 161–166
165
7.18–7.70 (m, 15H, Harom). 13C NMR (100 MHz, CDCl3):
d À4.5 (CH3Si), À4.5 (CH3Si), 18.5 ((CH3)3CSi), 26.1
((CH3)3CSi), 30.6 (d, J = 72.7 Hz, CH2P), 72.5 (d, J =
4.0 Hz, CHOH), 78.1 (CHPh), 126.7, 127.5, 128.2, 128.8
(d, J = 11.7 Hz), 130.5 (d, J = 9.5 Hz), 130.9 (d, J = 9.1),
131.9 (d, J = 9.1 Hz), 132.0 (d, J = 9.1 Hz), 141.4. 31P
NMR (81 MHz, CDCl3): d 36.60. HRMS (FAB+) Calcd
for C27H36O3PSi (MH+) 467.2171; found 467.2174.
NMR (81 MHz, CDCl3): d 37.43 HRMS (CI+) Calcd for
C21H22O3P (MH+) 353.1307; found 353.1321.
4.4. (1S,2R)-3-(Diphenylphosphinoyl)-1-phenylpropane-1,2-
diol syn-7
The procedure is the same as for anti-6, using the diastereo-
isomer syn-5 as a starting material (900 mg, 1.93 mmol),
obtaining 544 mg (80%) of syn-7 as a white solid. [a]D =
1
4.2.3. Reduction with Zn(BH4)2. To a solution of (S)-4
(1.0 g, 2.2 mmol) in anhydrous THF (80 mL) freshly pre-
pared15 Zn(BH4)2 0.14 M (410 mg, 30 mL, 4.3 mmol) was
slowly added at À78 °C. The reaction mixture was stirred
for 7 h before the addition of a saturated solution of
NH4Cl, and extracted with ethyl acetate (3 Â 40 mL).
The combined organic layers were dried over Na2SO4
and evaporated under reduced pressure to yield 1.0 g
(99%) of syn-5 and anti-6 in a ratio of 96:4, respectively.
The crude product was purified by column chromatogra-
phy (hexane–ethyl acetate 1:2) obtaining 900 mg (90%) of
syn-5 as a white solid.
À1.8 (c 0.7, CHCl3): lit.10 [a]D = À1.8 (c 0.7, CHCl3). H
NMR (400 MHz, CDCl3): d 2.3 (ddd, J = 15.0, 8.6,
2.4 Hz, 1H, CH2P), 2.45 (ddd, J = 15.0, 12.0, 10.0 Hz,
1H, CH2P), 4.11–4.19 (m, 1H, CHOH), 3.76 (b, 2H,
OH), 4.60 (d, J = 6.0 Hz, 1H, CHPh), 7.25–7.65 (m, 15H,
Harom). 13C NMR (100 MHz, CDCl3): d 32.7 (d, J =
69.8 Hz, CH2P), 71.6 (d, J = 3.0 Hz, CHOH), 78.0 (d,
J = 13.7 Hz, CHPh), 127.3, 128.2, 128.6, 128.9 (d, J =
12.1 Hz), 130.6 (d, J = 9.2 Hz), 130.9 (d, J = 9.1 Hz),
132.2, 140.0. 31P NMR (81 MHz, CDCl3): d 36.00. HRMS
(CI+) Calcd for C21H22O3P (MH+) 353.1307; found
353.1270.
4.2.3.1. (1S,2R)-1-[(tert-Butyldimethylsilyl)oxy]-3-(diphen-
140–
4.5. (4S,5S)-2,2-Dimethyl-4-phenyl-5-(diphenylphosphinoyl
methyl)-1,3-dioxolane syn-10
ylphos-phinoyl)-1-phenylpropan-2-ol
syn-5. Mp
1
142 °C, [a]D = +33.4 (c 2.5, CHCl3). H NMR (400 MHz,
CDCl3): d 0.08 (s, 3H, CH3Si), 0.14 (s, 3H, CH3Si), 0.97
(s, 9H, (CH3)3CSi), 2.13 (ddd, J = 15.0, 4.1 Hz, 1H,
CH2P), 2.56 (ddd, J = 15.0, 8.3, 1.6 Hz, 1H, CH2P), 4.27
(s, 1H, OH), 4.28–4.34 (m, 1H, CHOH), 4.93 (d, J =
4.8 Hz, 1H, CHPh), 7.40–7.88 (m, 15H, Harom). 13C
NMR (100 MHz, CDCl3): d À5.0 (CH3Si), À4.7 (CH3Si),
18.3 ((CH3)3CSi), 25.9 ((CH3)3CSi), 30.8 (d, J = 71.3 Hz,
CH2P), 71.4 (d, J = 4.6 Hz, CHOH), 76.7 (d, J =
13.7 Hz, CHPh), 127.4, 127.7, 128.0, 128.8 (d, J =
9.1 Hz), 128.9 (d, J = 10.6 Hz), 130.6 (d, J = 10.7 Hz),
131.2 (d, J = 9.1 Hz), 140.1. 31P NMR (81 MHz, CDCl3):
d 36.25. HRMS (FAB+) Calcd for C27H36O3PSi (MH+)
467.2171; found 467.2162.
To a solution of anti-8 (500 mg, 1.42 mmol) in acetonitrile
(30 mL) p-toluenesulfonic acid (81 mg, 0.42 mmol) and 2,2-
dimethoxypropane (295 mg, 0.35 mL, 2.8 mmol) were
added at room temperature. After 12 h, triethylamine
(43 mg, 0.1 mL, 0.42 mmol) was added. The volatiles were
eliminated under reduced pressure and the residue was
purified by column chromatography (ethyl acetate–hexane
1:1) to afford 466 mg (84%) of syn-10 as a white solid. Mp
137–139 °C. [a]D = +66.6 (c 1.5, CHCl3). 1H NMR
(400 MHz, CDCl3): d 1.32 (s, 3H, CH3), 1.33 (s, 3H,
CH3), 1.85 (ddd, J = 15.4, 3.0 Hz, 1H, CH2P), 2.19 (ddd,
J = 15.4, 9.4, 5.8 Hz, 1H, CH2P), 4.89–4.96 (m, 1H,
CHCH2P), 5.29 (d, J = 6.4 Hz, CHPh), 7.28–7.75 (m,
15H, Harom). 13C NMR (100 MHz, CDCl3): d 25.1
(CH3), 27.2 (CH3), 33.0 (d, J = 71.3 Hz, CH2P), 73.5 (d,
J = 4.5 Hz, CHCH2P), 80.2 (d, J = 10.6 Hz, CHPh),
108.8 (C(CH3)2), 126.9, 128.1, 128.2 (d, J = 12.1 Hz),
128.5 (d, J = 12.1 Hz), 128.6, 130.7 (d, J = 9.1 Hz), 131.4
(d, J = 10.6 Hz), 131.6 (d, J = 12.1 Hz), 137.4. 31P NMR
(81 MHz, CDCl3): d 31.56. HRMS (FAB+) Calcd for
C24H26O3P (MH+) 393.1620; found 393.1633.
4.3. (1S,2S)-3-(Diphenylphosphinoyl)-1-phenylpropane-1,2-
diol anti-8
To a solution of anti-6 (800 mg, 1.7 mmol) in anhydrous
THF (40 mL) n-tetrabutylammonium fluoride 1.0 M
(896 mg, 3.4 mL, 3.4 mmol) was added at 0 °C. The reac-
tion mixture was stirred for 4 h before the addition of a sat-
urated solution of NH4Cl. The organic layer was separated
and the aqueous layer was extracted with ethyl acetate
(3 Â 25 mL). The combined organic extracts were dried
over Na2SO4 and evaporated under reduced pressure.
The crude product was purified by column chromatogra-
phy (ethyl acetate–hexane 3:1) to afford 544 mg (90%) of
anti-8 as a white solid. Mp 164–165 °C, [a]D = +45.7 (c
4.6. (4S,5R)-2,2-Dimethyl-4-phenyl-5-(diphenylphosphinoyl
methyl)-1,3-dioxolane anti-9
The procedure is the same as for syn-10, using the diaste-
reoisomer syn-7 as starting material, obtaining 466 mg
(84%) of anti-9 as a white solid. Mp 144–145 °C.
1
1
2.4, CHCl3). H NMR (400 MHz, CDCl3): d 2.19 (ddd,
[a]D = +5.5 (c 1.5, CHCl3). H NMR (400 MHz, CDCl3):
J = 15.4, 8.2, 1.8 Hz, 1H, CH2P), 2.57 (ddd, J = 15.4,
12.0, 10.4 Hz, 1H, CH2P), 4.19–4.25 (m, 1H, CHOH),
4.42 (s, 2H, OH), 4.93 (d, J = 2.8 Hz, 1H, CHPh), 7.28–
7.60 (m, 15H, Harom). 13C NMR (100 MHz, CDCl3): d
29.5 (d, J = 72.1 Hz, CH2P), 71.6 (d, J = 4.6 Hz, CHOH),
76.2 (d, J = 12.2 Hz, CHPh), 126.1, 127.5, 128.4, 128.7 (d,
J = 3.8 Hz), 128.8 (d, J = 3.0 Hz), 130.5 (d, J = 9.8 Hz),
130.9 (d, J = 9.1 Hz), 132.0 (d, J = 2.3 Hz), 140.0. 31P
d 1.36 (s, 3H, CH3), 1.42 (s, 3H, CH3), 2.52 (ddd,
J = 14.8, 2.8 Hz, 1H, CH2P), 2.65 (ddd, J = 14.8, 9.2 Hz,
1H, CH2P), 4.08–4.15 (m, 1H, CHCH2P), 4.76 (d,
J = 8.0 Hz, CHPh), 7.31–7.71 (m, 15H, Harom). 13C
NMR (100 MHz, CDCl3): d 27.1 (CH3), 27.3 (CH3), 32.5
(d, J = 71.3 Hz, CH2P), 77.8 (d, J = 5.3 Hz, CHCH2P),
84.2 (d, J = 12.9 Hz, CHPh), 109.6 (C(CH3)2), 127.1,
128.3 (d, J = 11.4 Hz), 128.6 (d, J = 12.1 Hz), 128.7,